表紙
市場調查報告書

酵素結合免疫吸附法(ELISA)的全球市場:2020年∼2024年

Global Enzyme-linked Immunosorbent Assay (ELISA) Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 336918
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
酵素結合免疫吸附法(ELISA)的全球市場:2020年∼2024年 Global Enzyme-linked Immunosorbent Assay (ELISA) Market 2020-2024
出版日期: 2020年01月26日內容資訊: 英文 120 Pages
簡介

全球酵素結合免疫吸附法(ELISA)市場在2020年∼2024年的預測期間內,預計將以5%的年複合成長率增長,達到1億2,455萬美元的規模。市場成長的主要因素有高齡人口頻繁的診斷檢驗需求,此外,促銷活動的重要性日益提高,有望進一步推動市場增長。

本報告提供全球酵素結合免疫吸附檢測法(ELISA)市場相關調查分析,提供市場規模及成長率,市場趨勢,推動市場要素,課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

摘要整理

  • 市場概況

市場風景

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模2019
  • 市場預測:2019-2024年的預測

波特的五力分析

  • 波特的五力分析摘要
  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 對手的威脅
  • 市場情況

市場區隔:各終端用戶

  • 市場區隔
  • 各終端用戶比較:市場規模及預測2019-2024
  • 醫院及診斷中心
  • 研究所
  • 其他
  • 市場機會:終端用戶

客戶形勢

  • 概要

各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模與預測2019-2024
  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲地區
  • 南美
  • 主要國家
  • 市場機會:各地區

成長要素,課題,及趨勢

  • 市場成長要素
  • 交易量的成長要素-需求主導型成長
  • 交易量的成長要素-供給主導型成長
  • 交易量的成長要素-外部要素
  • 交易量的成長要素-需求轉移到鄰近市場
  • 價格上升要素-通貨膨脹
  • 價格成長要素-從低價格單位轉變到高價格單位
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 業者情勢
  • 形勢的創新

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Abbott Laboratories
  • Abcam Plc
  • Avantor Inc.
  • bioMerieux SA
  • bioMerieux SA
  • Danaher Corp.
  • Eppendorf AG
  • GlaxoSmithKline Plc
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

附錄

  • 調查範圍
  • 美金的貨幣換算比率
  • 調查方法
  • 簡稱的清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR41149

Technavio has been monitoring the global enzyme-linked immunosorbent assay (elisa) market and it is poised to grow by USD 124.55 mn during 2020-2024, progressing at a CAGR of 5% during the forecast period. Our reports on global enzyme-linked immunosorbent assay (elisa) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by demand for frequent diagnostic testing for aging population.In addition, growing importance of promotional activities is anticipated to boost the growth of the global enzyme-linked immunosorbent assay (elisa) market as well.

Market Segmentation

Technavio's global enzyme-linked immunosorbent assay (elisa) market is segmented as below:

End-user:

  • Hospitals And Diagnostics Center
  • Research Laboratories
  • Others

Geographic segmentation

  • North America
  • APAC
  • Europe
  • South America
  • MEA

Key Trends for global enzyme-linked immunosorbent assay (elisa) market growth

This study identifies growing importance of promotional activities as the prime reasons driving the global enzyme-linked immunosorbent assay (elisa) market growth during the next few years.

Prominent vendors in global enzyme-linked immunosorbent assay (elisa) market

We provide a detailed analysis of around 25 vendors operating in the global enzyme-linked immunosorbent assay (elisa) market, including some of the vendors such as Abbott Laboratories, Abcam Plc, Avantor Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., Eppendorf AG, GlaxoSmithKline Plc, Siemens Healthineers AG and Thermo Fisher Scientific Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End user placement
  • Hospitals and diagnostic centers - Market size and forecast 2019-2024
  • Research laboratories - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Abcam Plc
  • Avantor Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Eppendorf AG
  • GlaxoSmithKline Plc
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 4
  • 5.Key Finding 5
  • 6.Key Finding 6
  • 7.Key Finding 7
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Product / Service portfolio of key vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ million)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.End user placement - Market share 2019-2024 (%)
  • 23.Comparison by End user placement
  • 24.Hospitals and diagnostic centers - Market size and forecast 2019-2024 ($ million)
  • 25.Hospitals and diagnostic centers - Year-over-year growth 2019-2024 (%)
  • 26.Research laboratories - Market size and forecast 2019-2024 ($ million)
  • 27.Research laboratories - Year-over-year growth 2019-2024 (%)
  • 28.Others - Market size and forecast 2019-2024 ($ million)
  • 29.Others - Year-over-year growth 2019-2024 (%)
  • 30. Market opportunity by End user
  • 31.Customer landscape
  • 32.Market share by geography 2019-2024 (%)
  • 33.Geographic comparison
  • 34.North America - Market size and forecast 2019-2024 ($ million)
  • 35.North America - Year-over-year growth 2019-2024 (%)
  • 36.Europe - Market size and forecast 2019-2024 ($ million)
  • 37.Europe - Year-over-year growth 2019-2024 (%)
  • 38.APAC - Market size and forecast 2019-2024 ($ million)
  • 39.APAC - Year-over-year growth 2019-2024 (%)
  • 40.MEA - Market size and forecast 2019-2024 ($ million)
  • 41.MEA - Year-over-year growth 2019-2024 (%)
  • 42.South America - Market size and forecast 2019-2024 ($ million)
  • 43.South America - Year-over-year growth 2019-2024 (%)
  • 44.Key leading countries
  • 45.Market opportunity by geography ($ million)
  • 46.Impact of drivers
  • 47.Impact of challenges
  • 48.Landscape disruption
  • 49.Industry risks
  • 50.Vendors covered
  • 51.Market positioning of vendors
  • 52.Abbott Laboratories - Overview (1/3)
  • 53.Abbott Laboratories - Overview (2/3)
  • 54.Abbott Laboratories - Overview (3/3)
  • 55.Abbott Laboratories - Business segments
  • 56.Abbott Laboratories - Key offerings
  • 57.Abbott Laboratories - Key customers
  • 58.Abbott Laboratories - Segment focus
  • 59.Abcam Plc - Overview (1/3)
  • 60.Abcam Plc - Overview (2/3)
  • 61.Abcam Plc - Overview (3/3)
  • 62.Abcam Plc - Business segments
  • 63.Abcam Plc - Key offerings
  • 64.Abcam Plc - Key customers
  • 65.Abcam Plc - Segment focus
  • 66.Avantor Inc. - Overview (1/3)
  • 67.Avantor Inc. - Overview (2/3)
  • 68.Avantor Inc. - Overview (3/3)
  • 69.Avantor Inc. - Business segments
  • 70.Avantor Inc. - Key offerings
  • 71.Avantor Inc. - Key customers
  • 72.Avantor Inc. - Segment focus
  • 73.bioMerieux SA - Overview (1/3)
  • 74.bioMerieux SA - Overview (2/3)
  • 75.bioMerieux SA - Overview (3/3)
  • 76.bioMerieux SA - Business segments
  • 77.bioMerieux SA - Key offerings
  • 78.bioMerieux SA - Key customers
  • 79.bioMerieux SA - Segment focus
  • 80.Bio-Rad Laboratories Inc. - Overview (1/3)
  • 81.Bio-Rad Laboratories Inc. - Overview (2/3)
  • 82.Bio-Rad Laboratories Inc. - Overview (3/3)
  • 83.Bio-Rad Laboratories Inc. - Business segments
  • 84.Bio-Rad Laboratories Inc. - Key offerings
  • 85.Bio-Rad Laboratories Inc. - Key customers
  • 86.Bio-Rad Laboratories Inc. - Segment focus
  • 87.Danaher Corp. - Overview (1/3)
  • 88.Danaher Corp. - Overview (2/3)
  • 89.Danaher Corp. - Overview (3/3)
  • 90.Danaher Corp. - Business segments
  • 91.Danaher Corp. - Key offerings
  • 92.Danaher Corp. - Key customers
  • 93.Danaher Corp. - Segment focus
  • 94.Eppendorf AG - Overview (1/3)
  • 95.Eppendorf AG - Overview (2/3)
  • 96.Eppendorf AG - Overview (3/3)
  • 97.Eppendorf AG - Business segments
  • 98.Eppendorf AG - Key offerings
  • 99.Eppendorf AG - Key customers
  • 100.Eppendorf AG - Segment focus
  • 101.GlaxoSmithKline Plc - Overview (1/3)
  • 102.GlaxoSmithKline Plc - Overview (2/3)
  • 103.GlaxoSmithKline Plc - Overview (3/3)
  • 104.GlaxoSmithKline Plc - Business segments
  • 105.GlaxoSmithKline Plc - Key offerings
  • 106.GlaxoSmithKline Plc - Key customers
  • 107.GlaxoSmithKline Plc - Segment focus
  • 108.Siemens Healthineers AG - Overview (1/3)
  • 109.Siemens Healthineers AG - Overview (2/3)
  • 110.Siemens Healthineers AG - Overview (3/3)
  • 111.Siemens Healthineers AG - Business segments
  • 112.Siemens Healthineers AG - Key offerings
  • 113.Siemens Healthineers AG - Key customers
  • 114.Siemens Healthineers AG - Segment focus
  • 115.Thermo Fisher Scientific Inc. - Overview (1/3)
  • 116.Thermo Fisher Scientific Inc. - Overview (2/3)
  • 117.Thermo Fisher Scientific Inc. - Overview (3/3)
  • 118.Thermo Fisher Scientific Inc. - Business segments
  • 119.Thermo Fisher Scientific Inc. - Key offerings
  • 120.Thermo Fisher Scientific Inc. - Key customers
  • 121.Thermo Fisher Scientific Inc. - Segment focus
  • 122.Currency conversion rates for US$
  • 123.Research Methodology
  • 124.Validation techniques employed for market sizing
  • 125.Information sources
  • 126.List of abbreviations